Skip to content

Treatment of Keratoconus With Advanced Corneal Crosslinking

Treatment of Keratoconus With Advanced Corneal Crosslinking

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02425150
Enrollment
120
Registered
2015-04-23
Start date
2009-10-31
Completion date
2014-10-31
Last updated
2020-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Keywords

Keratoconus, Corneal crosslinking, Corneal biomechanics, Corneal densitometry, Scheimpflug photography

Brief summary

The purpose of this study was to determine whether mechanical compression of the cornea during corneal crosslinking for keratoconus using a sutured rigid contact lens can improve the optical outcomes of the treatment.

Detailed description

The study is designed as a prospective, open, randomized controlled trial involving patients aged 18-28 years of both genders with uni- or bilateral keratoconus planned for routine corneal crosslinking at the Department of Ophthalmology, Umeå University Hospital, Umeå, Sweden. The study involves 30+30 eyes with keratoconus, which are randomized to receive either conventional corneal crosslinking (n=30) using the Dresden protocol or a modified treatment - corneal reshaping and crosslinking (n=30), where a rigid contact lens is sutured to the cornea during the treatment to flatten the corneal curvature and potentially improve the optical outcome after the treatment. Patients are randomized utilizing a list of unique random numbers between 1 and 60. All patients are informed about the procedures before consenting to participate in the study. The study also involves 60 eyes of healthy age- and sex-matched control subjects. At baseline, before treatment, each eye is evaluated with autorefractometer measurement, best spectacle-corrected LogMAR visual acuity, Pentacam Scheimpflug photography, Goldmann applanation tonometry and biomicroscopy. The corneal biomechanical characteristics are assessed with applanation resonance tonometry and the ocular response analyzer. The investigations are repeated at 1 month, 6 months, 2 years and 5 years after the treatment.

Interventions

PROCEDURECorneal reshaping/crosslinking (CRXL)

The keratoconus cornea is treated with epithelial debridement in local anesthesia, is soaked in Riboflavin by repeated topical application during 30 minutes. A flat, rigid contact lens is sutured to the cornea and the cornea and is then irradiated with ultraviolet light 5.4 J/cm2 during 30 minutes.

PROCEDURECorneal Crosslinking (CXL)

The keratoconus cornea is treated with epithelial debridement in local anesthesia, is soaked in Riboflavin by repeated topical application during 30 minutes. The cornea and is then irradiated with ultraviolet light 5.4 J/cm2 during 30 minutes.

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients planned for corneal crosslinking. * Progressive keratoconus documented with Scheimpflug photography using the Pentacam Scheimflug camera and/or repeated subjective refraction and keratometry. * A keratoconus diagnosis based on the Amsler-Krumeich grading and the Total Deviation KC quantification value from the Belin-Ambrosio enhanced ectasia measurements of the Pentacam Scheimpflug camera, and an altered red reflex and/or an irregular cornea seen as distortion of the keratometric mires. * Minimum corneal thickness of 400 µm at the thinnest point after epithelial removal. * 18-28 years of age * No ocular abnormalities except keratoconus * No previous ocular surgery * No cognitive insufficiency interfering with the informed consent.

Exclusion criteria

* Age under 18 or over 28 * Any corneal abnormalities except keratoconus * Previous ocular surgery * Cognitive insufficiency.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in refraction1, 6, 24 and 60 months after the treatmentRefractive errors, including lower and higher order aberrations in the cornea

Secondary

MeasureTime frameDescription
Change from baseline in ETDRS LogMAR visual acuity1, 6, 24 and 60 months after the treatmentUncorrected and best spectacle corrected visual acuity measured with the Early treatment diabetic retinopathy study, graded in logarithmic values of the minimal angle of resolution
Change from baseline in corneal biomechanical stability measured with ORA1, 6, 24 and 60 months after the treatmentBiomechanical stability assessed with the ocular response analyzer
Change from baseline in corneal biomechanical stability measured with ART1, 6, 24 and 60 months after the treatmentBiomechanical stability assessed with the applanation resonance tonometer
Change from baseline in corneal biomechanical stability measured with GAT1, 6, 24 and 60 months after the treatmentBiomechanical stability assessed with the Goldmann applanation tonometer
Change from baseline in corneal densitometry1, 6, 24 and 60 months after the treatmentCorneal light reflectivity (back scatter) assessed with the Pentacam HR Scheimpflug camera

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026